市場調查報告書

甲狀腺癌診斷- 全球市場預測(2019年∼2027年)

Thyroid Cancer Diagnostics - Global Market Outlook (2019-2027)

出版商 Stratistics Market Research Consulting 商品編碼 956074
出版日期 內容資訊 英文 208 Pages
商品交期: 2-3個工作天內
價格
甲狀腺癌診斷- 全球市場預測(2019年∼2027年) Thyroid Cancer Diagnostics - Global Market Outlook (2019-2027)
出版日期: 2020年08月01日內容資訊: 英文 208 Pages
簡介

全球甲狀腺癌診斷市場,2019年成為24億美元的市場規模,在預測期間內預計以7.6%的年複合成長率成長,至2027年達到43億1,000萬美元。甲狀腺癌的盛行率上升,政府的舉措增加,研究的資金援助增加,及早期診斷和治療受到高度的關注等成為推動市場成長的主要要素。

本報告提供全球甲狀腺癌診斷市場的相關調查,市場機會和威脅,成長及阻礙因素,各技術、類型、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 成長要素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 終端用戶分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 全球甲狀腺癌診斷市場:各技術

  • 影像診斷
  • 血液檢驗
  • 切片檢查
  • 超音波
  • 放射性碘掃描
  • 磁振造影(MRI)掃描
  • 正子輻射斷層攝影(PET)掃描
  • 電腦斷層攝影(CT)掃描
  • 分子檢驗

第6章 全球甲狀腺癌診斷市場:各類型

  • 濾胞腺癌
  • 乳頭癌症

第7章 全球甲狀腺癌診斷市場:各終端用戶

  • 研究機關
  • 醫院、門診病人手術中心
  • 癌症診斷中心
  • 獨立型診斷實驗室
  • 影像診斷中心

第8章 全球甲狀腺癌診斷市場: 各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他的亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東、非洲地區

第9章 主要趨勢

  • 契約,夥伴關係,合作,合資企業
  • 收購、合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第10章 企業簡介

  • Bio-Rad Laboratories, Inc
  • General Electric
  • Koninklijke Philips N.V.
  • Abbott
  • F.Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthcare GmbH
  • 東芝
目錄

According to Stratistics MRC, the Global Thyroid Cancer Diagnostics market is accounted for $2.40 billion in 2019 and is expected to reach $4.31 billion by 2027 growing at a CAGR of 7.6% during the forecast period. Some of the key factors propelling the market growth include rising prevalence of thyroid cancer, increase in the number of initiatives by governments, rise in funding for research, and increasing emphasis on early diagnosis and treatment. However,

Lack of knowledge about exact causative factors and late diagnosis of the disease are some key factors restraining the growth of the market. Moreover, rising healthcare expenditure and increasing technological advancements are creating growth opportunities for the market.

Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in early stage and progresses with formation of lump in thyroid gland. If diagnosed in early stage it can be treated easily.

By technique, the imaging segment is anticipated to grow at the significant rate during the forecast period. Imaging tests remain the mainstay in thyroid cancer for purposes of disease diagnostics and cancer staging. Neck ultrasound or CT/MRI scans are the most recommended diagnostic tools for disease identification. Other imaging tests such as chest X-ray, bone scans, PET scan, and radioiodine scans are used for staging and identifying metastasis. Technological advancements and relatively high cost are key revenue generators for this segment in the thyroid cancer diagnostics market.

On the basis of geography, the market in Asia Pacific is expected to grow at the significant rate during the forecast period, owing to factors such as the increasing prevalence of thyroid cancer, a rise in consumer awareness improvement in healthcare infrastructure, and increase in disposable income. The market for thyroid cancer diagnostics in emerging countries such as China, India, and South Korea is expected to witness rapid growth during the forecast period.

Some of the key players in Thyroid Cancer Diagnostics Market include Bio-Rad Laboratories, Inc, General Electric, Koninklijke Philips N.V., Abbott, F.Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Siemens Healthcare GmbH, and Toshiba Corporation.

Techniques Covered:

  • Imaging
  • Blood Tests
  • Biopsy
  • Ultrasound
  • Radioiodine Scan
  • Magnetic Resonance Imaging (MRI) Scan
  • Positron Emission Tomography (PET) Scan
  • Computed Tomography (CT) Scan
  • Molecular Testing

Types Covered:

  • Follicular Carcinoma
  • Papillary Carcinoma

End Users Covered:

  • Research & Academic Institutes
  • Hospitals & Ambulatory Surgery Centers
  • Cancer Diagnostic Centers
  • Independent Diagnostic Labs
  • Diagnostic Imaging Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Thyroid Cancer Diagnostics Market, By Technique

  • 5.1 Introduction
  • 5.2 Imaging
  • 5.3 Blood Tests
  • 5.4 Biopsy
  • 5.5 Ultrasound
  • 5.6 Radioiodine Scan
  • 5.7 Magnetic Resonance Imaging (MRI) Scan
  • 5.8 Positron Emission Tomography (PET) Scan
  • 5.9 Computed Tomography (CT) Scan
  • 5.10 Molecular Testing

6 Global Thyroid Cancer Diagnostics Market, By Type

  • 6.1 Introduction
  • 6.2 Follicular Carcinoma
  • 6.3 Papillary Carcinoma

7 Global Thyroid Cancer Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Research & Academic Institutes
  • 7.3 Hospitals & Ambulatory Surgery Centers
  • 7.4 Cancer Diagnostic Centers
  • 7.5 Independent Diagnostic Labs
  • 7.6 Diagnostic Imaging Centers

8 Global Thyroid Cancer Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Bio-Rad Laboratories, Inc
  • 10.2 General Electric
  • 10.3 Koninklijke Philips N.V.
  • 10.4 Abbott
  • 10.5 F.Hoffmann-La Roche Ltd.
  • 10.6 Agilent Technologies, Inc.
  • 10.7 Illumina, Inc.
  • 10.8 Thermo Fisher Scientific, Inc.
  • 10.9 Siemens Healthcare GmbH
  • 10.10 Toshiba Corporation

List of Tables

  • Table 1 Global Thyroid Cancer Diagnostics Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
  • Table 3 Global Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
  • Table 4 Global Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
  • Table 5 Global Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
  • Table 6 Global Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
  • Table 7 Global Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
  • Table 8 Global Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
  • Table 9 Global Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
  • Table 10 Global Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
  • Table 11 Global Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
  • Table 12 Global Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
  • Table 13 Global Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
  • Table 14 Global Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
  • Table 15 Global Thyroid Cancer Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 16 Global Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
  • Table 17 Global Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
  • Table 18 Global Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
  • Table 19 Global Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
  • Table 20 Global Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
  • Table 21 North America Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 22 North America Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
  • Table 23 North America Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
  • Table 24 North America Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
  • Table 25 North America Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
  • Table 26 North America Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
  • Table 27 North America Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
  • Table 28 North America Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
  • Table 29 North America Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
  • Table 30 North America Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
  • Table 31 North America Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
  • Table 32 North America Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
  • Table 33 North America Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
  • Table 34 North America Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
  • Table 35 North America Thyroid Cancer Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 36 North America Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
  • Table 37 North America Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
  • Table 38 North America Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
  • Table 39 North America Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
  • Table 40 North America Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
  • Table 41 Europe Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 42 Europe Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
  • Table 43 Europe Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
  • Table 44 Europe Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
  • Table 45 Europe Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
  • Table 46 Europe Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
  • Table 47 Europe Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
  • Table 48 Europe Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
  • Table 49 Europe Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
  • Table 50 Europe Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
  • Table 51 Europe Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
  • Table 52 Europe Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
  • Table 53 Europe Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
  • Table 54 Europe Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
  • Table 55 Europe Thyroid Cancer Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 56 Europe Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
  • Table 57 Europe Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
  • Table 58 Europe Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
  • Table 59 Europe Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
  • Table 60 Europe Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
  • Table 61 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 62 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
  • Table 63 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
  • Table 64 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
  • Table 65 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
  • Table 66 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
  • Table 67 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
  • Table 68 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
  • Table 69 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
  • Table 70 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
  • Table 71 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
  • Table 72 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
  • Table 73 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
  • Table 74 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
  • Table 75 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 76 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
  • Table 77 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
  • Table 78 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
  • Table 79 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
  • Table 80 Asia Pacific Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
  • Table 81 South America Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 82 South America Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
  • Table 83 South America Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
  • Table 84 South America Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
  • Table 85 South America Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
  • Table 86 South America Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
  • Table 87 South America Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
  • Table 88 South America Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
  • Table 89 South America Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
  • Table 90 South America Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
  • Table 91 South America Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
  • Table 92 South America Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
  • Table 93 South America Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
  • Table 94 South America Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
  • Table 95 South America Thyroid Cancer Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 96 South America Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
  • Table 97 South America Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
  • Table 98 South America Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
  • Table 99 South America Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
  • Table 100 South America Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
  • Table 101 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 102 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
  • Table 103 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
  • Table 104 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
  • Table 105 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
  • Table 106 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
  • Table 107 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
  • Table 108 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
  • Table 109 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
  • Table 110 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
  • Table 111 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
  • Table 112 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
  • Table 113 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
  • Table 114 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
  • Table 115 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 116 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
  • Table 117 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
  • Table 118 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
  • Table 119 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
  • Table 120 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)